Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Orexo reports results from phase I study of OX-19 nasal spray for incontinence

April 30, 2008

Spectrum reports positive results from phase IIb study of LHRH antagonist ozarelix in BPH

April 28, 2008

Combination of dutasteride with tamsulosin approved for the treatment of BPH

April 24, 2008

Novel agents for treating urinary incontinence disclosed in recent Fujiyakuhin patent

April 23, 2008

AEterna completes recruitment for first phase III cetrorelix trial in BPH

April 17, 2008

Recent Janssen patent discloses new therapeutic agents for benign prostatic hyperplasia

April 16, 2008

Recent Ranbaxy patent reports novel therapeutic agents for urinary incontinence

April 10, 2008

Protox initiates phase II PRX-302 study in benign prostatic hyperplasia

April 10, 2008

In vitro profile of NK1 antagonist reported at the ACS meeting

April 9, 2008

Vivus enters funding collaboration with Deerfield for erectile dysfunction

April 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...